Toxicology Reagent DRI® Cannabinoids (THC) For Clinical Chemistry Analyzers

Features

• The DRI® Cannabinoid Assay is intended for the qualitative and semi-quantitative determination of cannabinoids (THC) in human urine
• Analyzers capable of maintaining a constant temperature, pipetting samples, mixing reagents, measuring enzymatic rates at 340 nm and timing the reaction accurately can be used to perform this assay
• Excellent correlation to GC/MS

More Information

• SDS